However, there was no significant difference in CAMSAP1 expression in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), pheochromocytoma and paraganglioma (PCPG), prostate cancer (PRAD), rectum adenocarcinoma (READ), and thyroid cancer (THCA) (Figure 2A). This evidence concerns the gene CAMSAP1 and prostate carcinoma.